Widely used:Recently Viewed
Clear AllQuality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$4,564 Mln
P/E Ratio
--
P/B Ratio
13.58
Industry P/E
--
Debt to Equity
0.03
ROE
-1.53 %
ROCE
-143.18 %
Div. Yield
0 %
Book Value
1.61
EPS
-1.35
CFO
$241.33 Mln
EBITDA
$92.73 Mln
Net Profit
$115.01 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Cellebrite DI (CLBT)
| -10.85 | -1.21 | -17.13 | 83.38 | 56.54 | -- | -- |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
|
|---|---|---|---|
|
Cellebrite DI (CLBT)
| 98.62 | -45.64 | -23.84 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 33.95 | 3,662.52 | -- | -9.53 | |
| 4.67 | 767.78 | -- | -7.99 | |
| 7.74 | 641.10 | -- | -53.22 | |
| 2.99 | 969.19 | -- | -0.36 |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt,... analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel. Address: 94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602 Read more
Founder, CEO & Director
Mr. Yossi Carmil
CEO & Director
Mr. Thomas E. Hogan
Headquarters
Petah Tikva
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Cellebrite DI Ltd (CLBT) stood at $ 691 Mln as on 31-Dec-24
The share price of Cellebrite DI Ltd (CLBT) is $19.64 (NASDAQ) as of 25-Apr-2025 16:00 EDT. Cellebrite DI Ltd (CLBT) has given a return of 56.54% in the last 3 years.
Cellebrite DI Ltd (CLBT) has a market capitalisation of $ 4,564 Mln as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Cellebrite DI Ltd (CLBT) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Cellebrite DI Ltd (CLBT) and enter the required number of quantities and click on buy to purchase the shares of Cellebrite DI Ltd (CLBT).
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel. Address: 94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602
The CEO & director of Mr. Yossi Carmil. is Cellebrite DI Ltd (CLBT), and CFO & Sr. VP is Mr. Thomas E. Hogan.
There is no promoter pledging in Cellebrite DI Ltd (CLBT).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
339
|
|
|
143
|
|
|
109
|
|
|
71
|
| Cellebrite DI Ltd. (CLBT) | Ratios |
|---|---|
|
Return on equity(%)
|
-152.88
|
|
Operating margin(%)
|
14.18
|
|
Net Margin(%)
|
-70.54
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Cellebrite DI Ltd (CLBT) was $0 Mln.
$0.08
(
